Volume 15, Number 6—June 2009
Diversity of Anaplasma phagocytophilum Strains, USA
We analyzed the structure of the expression site encoding the immunoprotective protein MSP2/P44 from multiple Anaplasma phagocytophilum strains in the United States. The sequence of p44ESup1 had diverged in Ap-variant 1 strains infecting ruminants. In contrast, no differences were detected between A. phagocytophilum strains infecting humans and domestic dogs.
Anaplasma phagocytophilum (order Rickettsiales) has a broad host range and infects humans as well as numerous other animal species (1). It has been known as a ruminant pathogen in Europe since at least 1932 but in recent years has emerged as a cause of disease in humans in the United States and Europe. The number of cases reported to the Centers for Disease Control and Prevention has increased from 537 in 2004 to 834 in 2007. Similarly, the number of dogs with clinical anaplasmosis has apparently increased. Strains clearly differ; not all appear to be capable of infecting humans or mice (2) or to cause persistent infections. These differences have stimulated the search for molecular markers of strain phenotypes and host tropisms. Although much strain variation has been identified, these markers have not been clearly linked to host tropisms except for 16S rRNA and the US Ap-variant 1 (Ap-V1). Ap-V1 differs from a human strain (Ap-ha) by a 2-bp substitution in the 16S rRNA sequence (3) and appears to be restricted to ruminant species (2,4). Because a 2-bp difference in 16S rRNA is minimally informative, we selected the msp2/p44 expression site to investigate other potential differences between Ap-V1 and other strains. In the related organism, A. marginale, the genomic repertoire of msp2 pseudogenes has been associated with the ability, or lack of ability, of strains to superinfect and cause epidemic spread of the organism (5).
Different isolates of the Ap-V1 strain were obtained from Rhode Island and Minnesota. Genomic DNA was extracted from infected goat blood, infected Ixodes scapularis ticks, and cell culture–grown isolates (ISE6) as described by Massung et al. (6). Other genomic DNA was isolated as described previously (7) from whole infected blood or HL-60 cultures. Dog blood was obtained from naturally infected animals identified by private practitioners in New York and Minnesota. Genomic DNA from the horse MRK strain of A. phagocytophilum (8) was isolated from infected equine neutrophils.
PCR amplification, sequencing, and analysis of the msp2/p44 expression site were performed by methods described previously (7). We used oligonucleotide primers AB1207 (5′-GGGAGTGCTCTGGTTAGATTTAGG-3′) and AB1221 (5′-ATAGAACAAGAGCAGGGAGAAGAC-3′) or AB1207 and AB1058 (5′-GAACCATCCCCTTAAAATACTTTC-3′) to amplify the msp2/p44 gene, the upstream gene p44ESup1, and the intergenic region between them. To amplify just the msp2/p44 gene in the expression site and to determine hypervariable region sequences, we used AB1221 and AB1266 (5′-GAAGAAGAGATTGGACTTTTGATCTGTC-3′) or AB1221 and AB1267 (5′-GAGGAAGAGATTGGACTTTTGAGCTGTC-3′). The sequences determined here have been assigned GenBank accession nos. FJ467331–FJ467340.
The expression site encoding MSP2/P44 is composed of the MSP2/P44 coding region itself, including a central hypervariable region, an intergenic region containing binding sites for a regulatory transcription factor ApxR, and an upstream gene known either as p44ESup1 or omp-1n (9,10). In our study, the p44ESup1 gene appeared to be experiencing purifying or stabilizing selection. Evolutionary analysis using MEGA4 (11; Nei-Gojobori method with the Jukes-Cantor correction) showed a low ratio of nonsynonymous-to-synonymous substitutions (mean dN 0.053, dS 0.296; dN/dS ratio 0.179). The Ap-V1 strains from Rhode Island and Minnesota shared many substitutions with a sheep strain from Norway that were not present in the other A. phagocytophilum strains (Figure 1). The p44ESup1gene in strains isolated from 5 persons from Wisconsin, Minnesota, and New York most closely resembled p44ESup1 in strains from clinical infections identified in 3 dogs from New York and Minnesota.
When we performed a concatenated analysis of the p44ESup1 and intergenic region p44ESup1 to msp2(p44) using maximum-likelihood methods, we found strong support for 3 clades: a clade of strains from eastern North America; a clade of strains from western North America; and a clade comprising a sheep strain from Norway, a dog strain from Sweden, and the 4 Ap-V1 strains from North America (Figure 2). Except for Ap-V1, the strains from eastern North America appeared to be closely related among themselves; the dog and human strains of A. phagocytophilum were indistinguishable from each other. Of note, a strain isolated from a dog in Sweden with clinical disease is on a separate branch from all US strains, including those from dogs in the United States.
The central hypervariable regions of msp2/p44 and the flanking conserved sequences from 34 Ap-V1 sequences were also aligned. The alignments showed the typical structure, including flanking LAKT residues and conserved framework residues such as C and WP described previously (9,12). Also, multiple hypervariable region variants were identified in each population of A. phagocytophilum (organisms characterized at a single time point from a single host). Some of the same variants were identified in different Rhode Island populations. No shared expression site variants were found between the Rhode Island and Minnesota Ap-V1 strain sequences.
When comparing the Ap-V1 expression site variants to genomic copies of the sequenced US human HZ strain, we found sequence identities >90% between 20/34 Ap-V1 variants, including 100% identities of 5/34 Ap-V1 variants. This level is comparable to that seen in most other US A. phagocytophilum strains. When compared with variants (non-HZ) identified directly from human infections, 10/34 Ap-V1 variants were >90% identical. In contrast, none of the Ap-V1 variants matched, with at least 70% identity, any previously identified MSP2/P44 expression site variants from strains from sheep in Norway. In general, little similarity was found between the msp2/p44 hypervariable regions of US and European strain variants.
Despite finding clear differences in the MSP2/P44 hypervariable region repertoire between US and European strains, we did not discover distinct repertoires in any US strains, including in Ap-V1. These findings agree with previous data that showed few differences by pulsed-field gel electrophoresis of 7 US strains (13) or by comparative microarray hybridization of 3 US strains (14). Our analysis focused on those hypervariable regions found frequently in the expression site. Because the genome repertoire contains ≈100 functional pseudogenes in each strain, complete genome sequencing may show differences in this repertoire not detected here.
The p44ESup1gene, upstream from msp2/p44 on the same polycistronic mRNA transcript, gave the most phylogenetically useful information. This gene clearly distinguished Ap-V1from other US strains. Moreover, the resemblance of the p44ESup1 gene in Ap-V1 and in a strain from a sheep in Norway suggests that it may be a marker for a ruminant tropism of A. phagocytophilum. Also, phylogenetic trees based on the p44ESup1 gene grouped A. phagocytophilum strains that cause clinical infections in US dogs or humans on the same branch. In fact, the genes from the 2 sources are indistinguishable, which may suggest a recent and common evolutionary origin of the US dog and human strains. Because these US data were obtained from a relatively small sampling of A. phagocytophilum infections (although from at least 2 states for the human, dog, and Ap-V1 strains), these findings should be verified in a larger dataset.
The sequence divergence between strains in p44ESup1 is similar to that in the downstream intergenic region. This intergenic region includes 2 divergent (54% and 58% identity in Ap-V1) binding sites for the transcription factor ApxR, which has been postulated to upregulate msp2/p44 transcription in mammalian cells (15). Either the ApxR transcription factor has low specificity for sequence compared with secondary structure or it does not have the same biological mode of action in Ap-V1 as in some other strains.
In summary, the Ap-V1 expression site encoding msp2/p44 was most similar to a strain from sheep in Norway. Strains causing clinical disease in humans and domestic dogs in the United States were indistinguishable.
Dr Morissette is completing a veterinary clinical pathology residency at the University of Florida. His research interests include structure and sequence diversity analysis and evolutionary study of antigenic variability in pathogens of veterinary interest.
We gratefully acknowledge the excellent technical assistance of Anna M. Lundgren and the contributions of samples from naturally infected dogs from Matt Eberts and Robin Jaeger.
This project was supported by National Institute of General Medical Sciences grant no. RO1 GM081714.
- Dumler JS, Barbet AF, Bekker CPJ, Dasch GA, Palmer GH, Ray SC, Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and ‘HGE agent’ as subjective synonyms of Ehrlichia phagocytophila. Int J Syst Evol Microbiol. 2001;51:2145–65.
- Massung RF, Priestley RA, Miller NJ, Mather TN, Levin ML. Inability of a variant strain of Anaplasma phagocytophilum to infect mice. J Infect Dis. 2003;188:1757–63.
- Massung RF, Mauel MJ, Owens JH, Allan N, Courtney JW, Stafford KC III, Genetic variants of Ehrlichia phagocytophila, Rhode Island, and Connecticut. Emerg Infect Dis. 2002;8:467–72.
- Massung RF, Mather TN, Levin ML. Reservoir competency of goats for the Ap-variant 1 strain of Anaplasma phagocytophilum. Infect Immun. 2006;74:1373–5.
- Futse JE, Brayton KA, Dark MJ, Knowles DP Jr, Palmer GH. Superinfection as a driver of genomic diversification in antigenically variant pathogens. Proc Natl Acad Sci U S A. 2008;105:2123–7.
- Massung RF, Levin ML, Munderloh UG, Silverman DJ, Lynch MJ, Gaywee JK, Isolation and propagation of the Ap-variant 1 strain of Anaplasma phagocytophilum in a tick cell line. J Clin Microbiol. 2007;45:2138–43.
- Barbet AF, Lundgren AM, Alleman AR, Stuen S, Bjöersdorff A, Brown RN, Structure of the expression site reveals global diversity in MSP2(P44) variants in Anaplasma phagocytophilum. Infect Immun. 2006;74:6429–37.
- Gribble DH. Equine ehrlichiosis. J Am Vet Med Assoc. 1969;155:462–9.
- Barbet AF, Meeus PFM, Bélanger M, Bowie MV, Ji J, Lundgren AM, Expression of multiple outer membrane protein sequence variants from a single genomic locus of Anaplasma phagocytophilum. Infect Immun. 2003;71:1706–18.
- Lin Q, Rikihisa Y, Ohashi N, Zhi N. Mechanisms of variable p44 expression by Anaplasma phagocytophilum. Infect Immun. 2003;71:5650–61.
- Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007;24:1596–9.
- Lin Q, Zhi N, Ohashi N, Horowitz HW, Aguero-Rosenfeld ME, Raffali G, Analysis of sequences and loci of p44 homologs expressed by Anaplasma phagocytophila in acutely infected patients. J Clin Microbiol. 2002;40:2981–8.
- Dumler JS, Asanovich KM, Bakken JS. Analysis of genetic identity of North American Anaplasma phagocytophilum strains by pulsed-field gel electrophoresis. J Clin Microbiol. 2003;41:3392–4.
- Hotopp JC, Lin M, Madupu R, Crabtree J, Angiuoli SV, Eisen JA, Comparative genomics of emerging human ehrlichiosis agents. PLoS Genet. 2006;2:e21 .
- Wang X, Cheng Z, Zhang C, Kikuchi T, Rikihisa Y. Anaplasma phagocytophilum p44 mRNA expression is differentially regulated in mammalian and tick host cells: involvement of the DNA binding protein ApxR. J Bacteriol. 2007;189:8651–9.
Suggested citation for this article: Morissette E, Massung RF, Foley JE, Alleman AR, Foley P, Barbet AF. Diversity of Anaplasma phagocytophilum strains, USA. Emerg Infect Dis [serial on the Internet]. 2009 Jun [date cited]. Available from http://wwwnc.cdc.gov/eid/article/15/6/08-1610
Comments to the Authors
Comments to the EID Editors
Please contact the EID Editors via our Contact Form.
- Page created: December 08, 2010
- Page last updated: December 08, 2010
- Page last reviewed: December 08, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)